Asthma Management

Airli is an Australian innovation established to assist consumers “breathe easy by making the invisible visible” by providing real time contextualized and relevant location based air quality health data. We have embraced AI & machine learning predictive algorithms to triangulate geospatial, weather and location based consumer information.

The initial roll out will focus on predictive pollen count analytics for asthma sufferers
the founders bring together deep and diverse domain experience anchored in geospatial research and technology to solve consumer related health problems through supporting behavioral change and digital analytics. Airli app’s technology, originally developed by Jacob Malana and team at The University of New South Wales is based on the premise that voice recognizing technology, cough and breathing sounds carry vital information on the state of the respiratory tract. Airli app was created to diagnose and measure the severity of a asthma, bronchiolitis, chronic and acute diseases such as pneumonia and chronic obstructive using this insight.

We have taken a machine learning approach to develop highly-accurate algorithms which diagnose disease from cough and respiratory sounds. Machine learning is an artificial intelligence technique that constructs algorithms with the ability to learn from data. In our approach, signatures that characterize the respiratory tract are extracted from cough and breathing sounds. We start by matching signatures in a large database of sound recordings with known clinical diagnoses. Our machine learning tools then find the optimum combination of these signatures to create an accurate diagnostic test or severity measure. 

                                  Pollen Alerts

Airli is designed to offer patient centric alerts reducing incidents of asthma and sudden burst of the need for acute are and emergency hospital admissions. it will have an analytics platform to analyze data from multiple data sources running AI and machine learning algorithms and is built on technology to provide complete data security and privacy the Airli product development is based on leveraging research engineering core competencies in creating this unique solution.

In Australia, the overall financial cost of asthma is estimated to be $30 billion and also the cost to patients due to the reduced quality of life is around $ 21.5 billion. 

                       Live health data

​

Airli received a minimum viable product grant from the NSW government to help develop its technology. Govt and CSIRO grants are in the pipeline for further funding of the entire project. Airli is working with a large not for profit asthma organization that intends to put the launch of the commercial product in its calendar.

“Airli brings together deep and diverse domain expertise anchored in geospatial research and technology to solve consumer related health problems through supporting behavioral change and analytics. We are seeking partners to further develop and progress our Airli product and services”